6090 — Human Metabolome Technologies Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Human Metabolome Technologies, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 262 | 237 | 262 | 270 | 225 |
| Depreciation | |||||
| Non-Cash Items | -27.8 | 4.7 | -11.2 | -14.5 | -40.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 25 | -37.1 | -100 | 14.5 | -87.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 324 | 285 | 237 | 374 | 209 |
| Capital Expenditures | -146 | -117 | -34.1 | -149 | -83.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -6.2 | 0.1 | 1.66 | -48.5 | -0.001 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -152 | -117 | -32.4 | -197 | -83.4 |
| Financing Cash Flow Items | -0.001 | -0.001 | -0.001 | -0.002 | -0.002 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 80.5 | -13.8 | -73.2 | -369 | -282 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 260 | 152 | 132 | -194 | -150 |